Showing results (21-30 of 289) with videos related to
Sort By:
Pageof 29
The European Journal of Neuroscience|November 9, 2018
Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's diseaseAnindita Bose, M Flint BealMethods in Molecular Biology (Clifton, N.J.)|September 14, 2011
Determination of neurotransmitter levels in models of Parkinson's disease by HPLC-ECDLichuan Yang, M Flint BealNeurochemical Research|May 9, 2019
PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them AllAlejandro Lloret, M Flint BealJournal of Neurochemistry|August 23, 2016
Mitochondrial dysfunction in Parkinson's diseaseAnindita Bose, M Flint BealThe Journal of Pharmacology and Experimental Therapeutics|June 16, 2012
Mitochondrial dysfunction in neurodegenerative diseasesAshu Johri, M Flint BealMolecular and Cellular Neurosciences|December 11, 2012
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseasesRajnish K Chaturvedi, M Flint BealBrain Research. Brain Research Reviews|November 5, 2005
Are mitochondria critical in the pathogenesis of Alzheimer's disease?P Hemachandra Reddy, M Flint BealNeurochemical Research|March 25, 2004
The energetics of Huntington's diseaseSusan E Browne, M Flint BealNeuromolecular Medicine|November 14, 2008
Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseasesPeter J Adhihetty, M Flint BealTrends in Molecular Medicine|January 26, 2008
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseP Hemachandra Reddy, M Flint BealPageof 29